Ekaterina Dadachova, PhD

Ekaterina Dadachova, PhD, of The University of Saskatchewan will investigate combining targeted radiation with immunotherapies for a novel and synergistic approach to treat advanced colorectal cancer, improving clinical outcomes.

Yekaterina Y. Zaytseva, PhD

Yekaterina Y. Zaytseva, PhD, of the University of Kentucky, will investigate new drug combinations to kill CRC cells with a BRAF mutation. These cells currently have a low response rate to existing treatments. 

Ashiq Masood, MD

Dr. Masood of Indiana University is studying ProAgio, a new protein that targets cells aiding cancer's survival. This approach could improve therapies for tough-to-treat tumors.

Caterina Suelzu, PhD

Dr. Suelzu of Anglia Ruskin University will investigate how fat tissue impacts the growth and spread of colorectal cancer, especially in people with obesity. 

Julia Carnevale, MD

Dr. Carnevale of UCSF will use cutting-edge technology to target multiple genes at once, seeking to uncover weaknesses in cancer cells and boost the body’s immune response. 

David Robbins, PhD

Dr. Robbins of Georgetown University aims to target and stop the circulating tumor cells responsible for forming metastatic tumors. Success could improve mCRC survival rates. 

Angelique Whitehurst, PhD

Melissa Fishel, PhD

Wenhan Zhu, PhD

Hyunyoung Jeong, PharmD, PhD

Boyi Gan, PhD

Binfeng Lu, PhD

Nilo Azad, MD

Christopher Lengner, PhD

Khosrow Rezvani, PhD

Brandon Bordeau, PhD

Karin Pelka, PhD

Raul Mostoslavsky, MD, PhD

Lisa Mielke, PhD

Eric Christenson, MD

Heather O'Hagan, PhD

Aleksander Popel, PhD

Bert Vogelstein, MD

Dae Yong Lee, PhD

Kelvin Pond, PhD